Case Reports
doi: 10.1046/j.1365-2141.2003.04708.x.
Effective treatment of hereditary haemochromatosis with desferrioxamine in selected cases
Affiliations
- PMID: 14632789
- DOI: 10.1046/j.1365-2141.2003.04708.x
Item in Clipboard
Case Reports
Effective treatment of hereditary haemochromatosis with desferrioxamine in selected cases
Br J Haematol.
2003 Dec.
Free article
Abstract
The treatment of iron overload by s.c. desferrioxamine (DFO) was studied in three patients with hereditary haemochromatosis in which phlebotomy treatment was not, or transiently not, possible because of their serious clinical condition or the lack of appropriate peripheral veins. Repeated non-invasive liver iron concentration measurements by superconducting quantum interference device biosusceptometry showed that DFO treatment (2 g/d for 9-11 months) was as effective (liver iron elimination rate: 12 mg/d) as normal phlebotomy treatment (5.9 or 14.3 mg/d respectively) with weekly 500-ml blood removals. This demonstrates that DFO is an effective alternative therapy for haemochromatosis when phlebotomy is not possible.
Similar articles
-
Non-invasive liver iron quantification by SQUID-biosusceptometry and serum ferritin iron as new diagnostic parameters in hereditary hemochromatosis.Blood Cells Mol Dis. 2002 Nov-Dec;29(3):451-8. doi: 10.1006/bcmd.2002.0583. Blood Cells Mol Dis. 2002. PMID: 12547235
-
[Hereditary hemochromatosis].Rev Gastroenterol Peru. 2001 Jan-Mar;21(1):42-55. Rev Gastroenterol Peru. 2001. PMID: 12170286 Review. Portuguese.
-
Iron absorption in normal subjects and patients with idiopathic haemochromatosis: relationship with serum ferritin concentration.Gut. 1975 Mar;16(3):188-92. doi: 10.1136/gut.16.3.188. Gut. 1975. PMID: 804432 Free PMC article.
-
Intramuscular deferoxamine in hereditary hemochromatosis.Am J Hematol. 2006 Mar;81(3):225-6. doi: 10.1002/ajh.20450. Am J Hematol. 2006. PMID: 16493613 No abstract available.
-
Iron overload disorders: natural history, pathogenesis, diagnosis, and therapy.Crit Rev Clin Lab Sci. 1983;19(3):205-66. doi: 10.3109/10408368309165764. Crit Rev Clin Lab Sci. 1983. PMID: 6373141 Review.
Cited by
-
Iron and liver fibrosis: Mechanistic and clinical aspects.World J Gastroenterol. 2019 Feb 7;25(5):521-538. doi: 10.3748/wjg.v25.i5.521. World J Gastroenterol. 2019. PMID: 30774269 Free PMC article. Review.
-
Chelation therapy for iron overload.Curr Gastroenterol Rep. 2007 Mar;9(1):74-82. doi: 10.1007/s11894-008-0024-9. Curr Gastroenterol Rep. 2007. PMID: 17335681 Review.
-
Iron homeostasis and post-hemorrhagic hydrocephalus: a review.Front Neurol. 2024 Jan 12;14:1287559. doi: 10.3389/fneur.2023.1287559. eCollection 2023. Front Neurol. 2024. PMID: 38283681 Free PMC article. Review.
-
Molecular and clinical aspects of iron homeostasis: From anemia to hemochromatosis.Wien Klin Wochenschr. 2006 Aug;118(15-16):442-62. doi: 10.1007/s00508-006-0653-7. Wien Klin Wochenschr. 2006. PMID: 16957974 Review.
-
Revisiting the intersection of amyloid, pathologically modified tau and iron in Alzheimer's disease from a ferroptosis perspective.Prog Neurobiol. 2020 Jan;184:101716. doi: 10.1016/j.pneurobio.2019.101716. Epub 2019 Oct 8. Prog Neurobiol. 2020. PMID: 31604111 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
